Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1672107
Max Phase: Preclinical
Molecular Formula: C23H14N6Na2O10S2
Molecular Weight: 600.55
Molecule Type: Small molecule
Associated Items:
ID: ALA1672107
Max Phase: Preclinical
Molecular Formula: C23H14N6Na2O10S2
Molecular Weight: 600.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(S(=O)(=O)[O-])c(Nc3nc(O)nc(O)n3)c2)c2c1C(=O)c1ccccc1C2=O.[Na+].[Na+]
Standard InChI: InChI=1S/C23H16N6O10S2.2Na/c24-18-15(41(37,38)39)8-13(16-17(18)20(31)11-4-2-1-3-10(11)19(16)30)25-9-5-6-14(40(34,35)36)12(7-9)26-21-27-22(32)29-23(33)28-21;;/h1-8,25H,24H2,(H,34,35,36)(H,37,38,39)(H3,26,27,28,29,32,33);;/q;2*+1/p-2
Standard InChI Key: GVOXJNFFTBQRER-UHFFFAOYSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 600.55 | Molecular Weight (Monoisotopic): 600.0369 | AlogP: 1.62 | #Rotatable Bonds: 6 |
Polar Surface Area: 272.09 | Molecular Species: ACID | HBA: 14 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -3.91 | CX Basic pKa: 0.95 | CX LogP: 0.27 | CX LogD: -0.16 |
Aromatic Rings: 4 | Heavy Atoms: 41 | QED Weighted: 0.11 | Np Likeness Score: -0.49 |
1. Baqi Y, Hausmann R, Rosefort C, Rettinger J, Schmalzing G, Müller CE.. (2011) Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor., 54 (3): [PMID:21207957] [10.1021/jm1012193] |
Source(1):